Dr. Daniel Levy

Dr. Levy, is Director of the Framingham Heart Study in Framingham Massachusetts. Dr Levy is a fellow of the American College of Cardiology and an active member of the AHA Clinical Council on Cardiology, AHA Council on Hypertension, and the American Society of Hypertension. In addition, Dr Levy serves on the American College of Cardiology Committee on Hypertensive Diseases and National Cholesterol Education Program's Adult Treatment Panel III (ATP III). He was a member of the Writing Committee for JNC VI.

Dr. Levy is Associate Clinical Professor of Medicine at Harvard Medical School and Associate Professor of Medicine at the Boston School of Medicine. Dr Levy has published well over 150 articles in leading cardiovascular and scientific journals, as well as a book on the Framingham Heart Study. He serves as a reviewer for numerous medical journals including Circulation, New England Journal of Medicine, Lancet, and JAMA. He serves on the editorial boards of JACC, Hypertension, Journal of Hypertension, and the American Journal of Medicine.

Dr Levy has been the recipient of many awards and honors, the most recent being the National Institutes of Health Director's Award given for his research achievements at the Framingham Heart Study. His main areas of research interest include the epidemiology of hypertension, the epidemiology of left ventricular hypertrophy, the epidemiology of heart failure, the prevention of coronary heart disease, and the diagnosis and treatment of lipid disorders.